BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29124549)

  • 1. Benefit of Surgical Resection of the Primary Tumor in Patients Undergoing Chemotherapy for Stage IV Colorectal Cancer with Unresected Metastasis.
    Maroney S; de Paz CC; Reeves ME; Garberoglio C; Raskin E; Senthil M; Namm JP; Solomon N
    J Gastrointest Surg; 2018 Mar; 22(3):460-466. PubMed ID: 29124549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical Resection of the Primary Tumor in Stage IV Colorectal Cancer Without Metastasectomy is Associated With Improved Overall Survival Compared With Chemotherapy/Radiation Therapy Alone.
    Gulack BC; Nussbaum DP; Keenan JE; Ganapathi AM; Sun Z; Worni M; Migaly J; Mantyh CR
    Dis Colon Rectum; 2016 Apr; 59(4):299-305. PubMed ID: 26953988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of primary tumor resection among chemotherapy-treated patients with synchronous stage IV colorectal cancer: a survival analysis.
    Tsang WY; Ziogas A; Lin BS; Seery TE; Karnes W; Stamos MJ; Zell JA
    J Gastrointest Surg; 2014 Mar; 18(3):592-8. PubMed ID: 24297651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: A nationwide population-based propensity-score adjusted study in the Netherlands.
    't Lam-Boer J; Van der Geest LG; Verhoef C; Elferink ME; Koopman M; de Wilt JH
    Int J Cancer; 2016 Nov; 139(9):2082-94. PubMed ID: 27342618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients With Stage IV Colorectal Cancer: A Canadian Province Experience.
    Ahmed S; Fields A; Pahwa P; Chandra-Kanthan S; Zaidi A; Le D; Haider K; Reeder B; Leis A
    Clin Colorectal Cancer; 2015 Dec; 14(4):e41-7. PubMed ID: 26140732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database.
    van Rooijen KL; Shi Q; Goey KKH; Meyers J; Heinemann V; Diaz-Rubio E; Aranda E; Falcone A; Green E; de Gramont A; Sargent DJ; Punt CJA; Koopman M
    Eur J Cancer; 2018 Mar; 91():99-106. PubMed ID: 29353165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment.
    Poultsides GA; Servais EL; Saltz LB; Patil S; Kemeny NE; Guillem JG; Weiser M; Temple LK; Wong WD; Paty PB
    J Clin Oncol; 2009 Jul; 27(20):3379-84. PubMed ID: 19487380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival outcomes following primary tumor resection for patients with incurable metastatic colorectal carcinoma: Experience from a single institution.
    Lau JW; Chang HS; Lee KY; Gwee YX; Lee WQ; Chong CS
    J Dig Dis; 2018 Sep; 19(9):550-560. PubMed ID: 30117288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of palliative resection for asymptomatic primary tumor in patients with unresectable stage IV colorectal cancer.
    Yun JA; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK
    Dis Colon Rectum; 2014 Sep; 57(9):1049-58. PubMed ID: 25101600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Tumor Resection for Stage IV Colorectal Cancer in the Era of Targeted Chemotherapy.
    Shida D; Boku N; Tanabe T; Yoshida T; Tsukamoto S; Takashima A; Kanemitsu Y
    J Gastrointest Surg; 2019 Nov; 23(11):2144-2150. PubMed ID: 30484063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary tumor location as a predictor of the benefit of palliative resection for colorectal cancer with unresectable metastasis.
    Zhang RX; Ma WJ; Gu YT; Zhang TQ; Huang ZM; Lu ZH; Gu YK
    World J Surg Oncol; 2017 Jul; 15(1):138. PubMed ID: 28750680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonoperative management of primary colorectal cancer in patients with stage IV disease.
    Scoggins CR; Meszoely IM; Blanke CD; Beauchamp RD; Leach SD
    Ann Surg Oncol; 1999; 6(7):651-7. PubMed ID: 10560850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of adjuvant chemotherapy in patients with curatively resected stage IV colorectal cancer.
    Kobayashi H; Kotake K; Sugihara K;
    Medicine (Baltimore); 2015 May; 94(17):e696. PubMed ID: 25929899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
    Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
    JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bevacizumab efficacy in metastatic colorectal cancer is dependent on primary tumor resection.
    Ghiringhelli F; Bichard D; Limat S; Lorgis V; Vincent J; Borg C; Berthou J; Orry D; Ortega-Deballon P; Lakkis Z; Facy O; Heyd B; Rat P; Nerich V; Ladoire S
    Ann Surg Oncol; 2014 May; 21(5):1632-40. PubMed ID: 24419756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Impact of Palliative Primary Tumor Resection for Unresectable Stage 4 Colorectal Cancer: Using a Propensity Score Analysis.
    Shida D; Hamaguchi T; Ochiai H; Tsukamoto S; Takashima A; Boku N; Kanemitsu Y
    Ann Surg Oncol; 2016 Oct; 23(11):3602-3608. PubMed ID: 27272107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming the challenges of primary tumor management in patients with metastatic colorectal cancer unresectable for cure and an asymptomatic primary tumor.
    Matsumoto T; Hasegawa S; Matsumoto S; Horimatsu T; Okoshi K; Yamada M; Kawada K; Sakai Y
    Dis Colon Rectum; 2014 Jun; 57(6):679-86. PubMed ID: 24807591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Relevance of Palliative Primary Tumor Removal in 37,793 Metastatic Colorectal Cancer Patients: A Population-Based, Propensity Score-Adjusted Trend Analysis.
    Tarantino I; Warschkow R; Worni M; Cerny T; Ulrich A; Schmied BM; Güller U
    Ann Surg; 2015 Jul; 262(1):112-20. PubMed ID: 25373464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modern-day palliative chemotherapy for metastatic colorectal cancer: does colonic resection affect survival?
    Lau JWL; Chang HSY; Lee KY; Gwee YX; Lee WQ; Chong CS
    ANZ J Surg; 2018 Nov; 88(11):E772-E777. PubMed ID: 29938886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncological benefit of primary tumor resection with high tie lymph node dissection in unresectable colorectal cancer with synchronous peritoneal metastasis: a propensity score analysis of data from a multi-institute database.
    Furuhata T; Okita K; Nishidate T; Hirata K; Ohnishi H; Kobayashi H; Kotake K; Sugihara K;
    Int J Clin Oncol; 2015 Oct; 20(5):922-7. PubMed ID: 25762168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.